About Gujarat Inject (Kerala) Ltd
Gujarat Inject (Kerala) initially a joint-sector venture to manufacture intravenous fluids but now primarily engaged in the trading of goods. The company, promoted by Gujarat Inject Limited and the Kerala State Industrial Development Corporation, transitioned from pharmaceutical production to textile trading, focusing on integrity and stakeholder responsibility.
Founded
1991
CEO
Murli Shivshankaran Nair
Employees
3
HQ
Vadodara, India
Finished Products
1Income from Operations
₹24.83Cr2sales
₹0.17CrRaw Materials
1Cost of Materials consumed
₹23.18Cr2Cost Of Goods Sold
₹0.15CrAbout Gujarat Inject (Kerala) Ltd
Gujarat Inject (Kerala) initially a joint-sector venture to manufacture intravenous fluids but now primarily engaged in the trading of goods. The company, promoted by Gujarat Inject Limited and the Kerala State Industrial Development Corporation, transitioned from pharmaceutical production to textile trading, focusing on integrity and stakeholder responsibility.
Founded:1991
CEO:Murli Shivshankaran Nair
Employees:3
HQ:Vadodara, India
Finished Products
1Income from Operations
₹24.83Cr2sales
₹0.17CrRaw Materials
1Cost of Materials consumed
₹23.18Cr2Cost Of Goods Sold
₹0.15CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹14
52W Low
₹2
Volume683.30K
Avg VolumeN/A
Beta-0.05
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
52.00x
Valuation
P/B Ratio
12.87x
Valuation
EPS
₹0.20
Valuation
Dividend Yield
0.00%
Valuation
ROE
15.34%
Profitability
ROCE
21.17%
Profitability
Revenue by Segment
Contribution & growth by business line
TradingRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.00x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
382.1%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.